Trial Profile
A Multicenter, Open-label, Non-controlled, Single-arm Phase IV Clinical Trial to Evaluate the Efficacy and Safety of Jublia in Mild to Moderate Toenail Onychomycosis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 28 Apr 2021
Price :
$35
*
At a glance
- Drugs Efinaconazole (Primary)
- Indications Onychomycosis
- Focus Therapeutic Use
- Sponsors Dong-A ST
- 26 Apr 2021 Status changed from active, no longer recruiting to completed.
- 06 May 2019 Planned End Date changed from 1 Oct 2019 to 31 Dec 2019.
- 06 May 2019 Planned primary completion date changed from 31 Aug 2019 to 31 Dec 2019.